Skip to main content

Advertisement

SpringerLink
Log in

18FDG-PET applications for cartilage neoplasms

  • Scientific Article
  • Published:
Skeletal Radiology Aims and scope Submit manuscript

Abstract

Objective

To assess the value of [18F]fluoro-2-deoxy-d-glucose positron emission tomography (18FDG-PET) in defining aggressive cartilage neoplasms, particularly those with problematic or borderline histologic, imaging and clinical characteristics.

Design and patients

From 2000 to 2003, 29 cartilage lesions were studied with whole-body 18FDG-PET scans (Siemens Ecat Exact, Knoxville, Tenn.). Analyses of data in 20 females and nine males, 11–85 years old, were based on maximum standard uptake values (SUVs) in regions of interest (ROIs) on axial 3.37 mm thick, 3×3 pixel images. A statistically significant maximum SUV cutoff of 2.0 was used to distinguish benign from malignant cartilage neoplasms and correlated with the postoperative histopathologic findings.

Results

In 26 operated cases the overall sensitivity of whole-body 18FDG-PET in separating benign and malignant lesions was 90.9% (10/11), specificity 100% (18/18) and accuracy 96.6%.

Conclusions

Whole-body 18FDG-PET is a valuable adjunct in identifying primary, recurrent and metastatic cartilage malignancies. It supplements classic histology and morphologic imaging with functional data which may facilitate management in individual cases.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1A―H
Fig. 2A, B
Fig. 3A, B
Fig. 4A, B
Fig. 5A, B
Fig. 6
Fig. 7
Fig. 8A―D
Fig. 9

Similar content being viewed by others

References

  1. Evans HL, Ayala AG, Romsdah MM. Prognostic factors in chondrosarcoma of bone. Cancer 1977; 40:818–831.

    Google Scholar 

  2. Mankin HJ, Lange TA, Spanier SS. The hazards of biopsy in patients with malignant primary bone and soft tissue tumors J Bone Joint Surg Am 1982; 64:1121–1127.

    CAS  Google Scholar 

  3. Rosenthal DJ, Schiller AL, Mankin HJ. Chondrosarcoma: correlation of radiological and histological grade. Radiology 1984; 150:21–26.

    CAS  PubMed  Google Scholar 

  4. Unni K. Dahlin’s bone tumors: general aspects and data on 11,087 cases, 5th edn. Philadelphia: Lippincott-Raven, 1996:143–183.

  5. Som P, Atkins HL, Bandaypadhyay D, et al. A fluorinated glucose analog, 2-fluoro-2-glucose (F18): nontoxic tracer for rapid tumor detection. J Nucl Med 1980; 21:670–675.

    CAS  PubMed  Google Scholar 

  6. Messa C, Landoni C, Pozzaato C, et al. Is there a role for FDG-PET in the diagnosis of musculoskeletal neoplasms? J Nucl Med 2000; 41:170–317[AU: PLEASE CHECK PAGE NOS.].

    Google Scholar 

  7. Cook G, Fogelman I. The role of positron emission tomography in skeletal disease. Semin Nucl Med 2001; 31:50–61.

    CAS  PubMed  Google Scholar 

  8. Kole AC, Nieweg OE, Hoekstra HJ, et al. F18 assessment of glucose metabolism in bone tumors. J Nucl Med 1998; 39:810–815.

    CAS  PubMed  Google Scholar 

  9. Kern KA, Brunetti A, Norton JA, et al. Metabolic imaging of human extremity musculoskeletal tumors by PET. J Nucl Med 1998; 29:181–186.

    Google Scholar 

  10. Dehdashti FD, Siegel GA, Griffeth LK, et al. Benign vs malignant intraosseous lesions: discrimination by means of PET with 2-(F18)-fluoro-2-deoxy-d-glucose. Radiology 1996; 200:243–247.

    CAS  PubMed  Google Scholar 

  11. Eary JF, Conrad E, Bruckner JD, et al Quantitative (F18) fluorodeoxyglucose positron emission tomography in pretreatment and grading of sarcoma. Clin Cancer Res 1998; 4:1215–1220.

    Google Scholar 

  12. Brenner W, Conrad EU, Eary JF. FDG PET imaging for grading and prediction of outcome in chondrosarcoma patients. Eur J Nucl Med Mol Imaging 2004; 31:189–195.

    Article  PubMed  Google Scholar 

  13. Schulte M, Brecht-Krauss D, Heymer B, et al. Grading of tumors and tumorlike lesions of bone: evaluation by FDG PET. J Nucl Med 2000; 41:1695–1701.

    CAS  PubMed  Google Scholar 

  14. Gilkey FW, Moser RP. The biology of cartilage. In: Moser RP, ed. Cartilaginous tumors of the skeleton. Philadelphia: Hanley and Belfus, 1990:1–7.

  15. Feldman F, VanHeertum R, Manoj C.18FDG PET scanning of benign and malignant musculoskeletal lesions. Skeletal Radiol 2003; 32:201–208.

    PubMed  Google Scholar 

  16. Aoki J, Watanabe H, Shinozaki T, et al. FDG PET in differential diagnosis and grading of chondrosarcomas. J Comput Assist Tomogr 1999; 23:603–608.

    Article  CAS  PubMed  Google Scholar 

  17. Aoki J, Watanabe H, Shinozaki T, et al. FDG PET of primary benign and malignant bone tumors: standardized uptake value in 52 lesions. Radiology 2001; 219:774–777.

    CAS  PubMed  Google Scholar 

  18. Arsos G, Venizelos I, Karatzas N, et al. Low grade chondrosarcomas: a difficult target for radionuclide imaging. Eur J Radiol 2002; 43:66–72.

    Article  PubMed  Google Scholar 

  19. Hammacher K, Coenen HH, Stocklin G. Efficient stereospecific synthesis of no-carrier-added 2-[18F]fluoro-2-deoxy-d-glucose using aminopolyether supported nucleophilic substitution. J Nucl Med 1986; 27:235–238.

    PubMed  Google Scholar 

  20. Pritchard D, Unni K. Chondrosarcoma. International Skeletal Society closed meeting syllabus, Stockholm, Sweden, Aug 25, 1992.

  21. Personal communication, Prof. G. Steiner, Chief of Pathology, Orthopedic Institute, NYC.

  22. Bredella M, Caputo GR, Steinbach LS. Value of PDG positron imaging in conjunction with MRI for evaluating therapy response in patients with musculoskeletal sarcomas. AJR Am J Roentgenol 2002; 179:1145–1150.

    PubMed  Google Scholar 

  23. Franzius C, Sciuk, J, Brinkschmidt C, et al. Evaluation of chemo-therapy response in primary bone tumors with F-18 FDG positron emission tomography compared with histologically assessed tumor necrosis. Clin Nucl Med 2000; 25:874–881.

    Article  CAS  PubMed  Google Scholar 

  24. Franzius C, Daldrup-Link, H, Wagner-Bohn A, et al. FDG-PET for detection of recurrences from malignant primary bone tumors: comparison with conventional imaging. Ann Oncol 2002; 13:157–160.

    Article  CAS  PubMed  Google Scholar 

  25. Zasadny KR, Wahl RL. Standardized uptake values in normal tissues at PET with 2-(F18) fluoro-2-deoxy-d-glucose. Variations with body weight and a method for correction. Radiology 1993; 89:847–850.

    Google Scholar 

  26. Kubota R, Yamada S, Kubota K, et al. Intratumoral distribution of fluorine 18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissue studied by microautoradiography. J Nucl Med 1992; 33:1972–1980.

    CAS  PubMed  Google Scholar 

  27. Guhlmann A, Brechy-Krauss D, Suger G, et al. Chronic osteomyelitis: detection with FDG PET and correlation with histopathologic findings. Radiology 1998; 206:749–754.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radiology, New York Presbyterian Medical Center, 622 W. 168 Street, New York, NY 10032, USA

    Frieda Feldman, Ronald Van Heertum & Chitra Saxena

  2. Department of Surgical Pathology, New York Presbyterian Medical Center, 622 W. 168 Street, New York, NY 10032, USA

    May Parisien

Authors
  1. Frieda Feldman
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ronald Van Heertum
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Chitra Saxena
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. May Parisien
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Frieda Feldman.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Feldman, F., Heertum, R.V., Saxena, C. et al. 18FDG-PET applications for cartilage neoplasms. Skeletal Radiol 34, 367–374 (2005). https://doi.org/10.1007/s00256-005-0894-y

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00256-005-0894-y

Keywords

Search

Navigation